This editorial demonstrates how cancer immunotherapy technologies can achieve immune tolerance in autoimmunity and transplantation, suggesting novel therapeutic strategies.
Key Points
Immunotherapies can reverse typical anti-tumor action to promote immune tolerance in autoimmune diseases and transplant settings.
Research highlights regulatory T cell engineering and innovative CRISPR technologies as promising avenues for enhancing immune tolerance.
New approaches with cancer therapy-derived designs offer specific targeting options, potentially minimizing harmful side effects in treating autoimmunity.
Continued advancements may redefine therapeutic applications, making immunotherapy a vital strategy in tackling autoimmune issues and enhancing transplant success.